Serial dilution is a recurring financing pattern, rather than a single share-count increase. This guide builds a multi-period financing record and tests its effect on per-share asset backing. For an initial review of a new filing or alert, start with How to Spot Dilution Risk.
Build a financing ledger
Start with the Share Changes table, then reconcile each observation to the issuer's disclosures. Cached changes can reflect corporate actions or revisions as well as issuance. Use a consistent split-adjusted share basis and record the date attached to every figure.
| Ledger field | What to record | Why it matters |
|---|---|---|
| Share-count basis | Period-end shares, cover-page date, and split adjustment | Different observation dates can create misleading comparisons |
| Financing | Common shares issued, price, gross proceeds, and fees | Identifies what capital arrived for the shares created |
| Additional claims | Warrants, convertibles, resets, and exercise terms | A financing may create future issuance beyond the shares already reported |
| Cash use | Operating consumption, debt repayment, acquisitions, or investment | Distinguishes additional resources from funds already spent |
| Per-share effect | Comparable asset backing and earnings before and after | Total capital can rise while each share's claim falls |
Read the financial statements, equity and debt notes, financing prospectus, and subsequent events. The SEC's How to Read a 10-K describes where to find the statements and supporting disclosures. Repeat the ledger across several periods; a count of offerings alone does not show whether value per share improved.
Worked example: more cash, less NCAV per share
Assume a hypothetical company has 10 million of NCAV and 10 million shares: 1.00 of NCAV per share. It then issues 20 million shares at 0.50, raising 10 million before fees. Immediately after the raise, with no other changes, NCAV is 20 million and shares are 30 million: approximately 0.67 per share.
The company has more capital, but reported NCAV per share is lower. This example excludes financing fees, cash consumption, changes in liabilities, and any future return on the proceeds. It illustrates the arithmetic; it does not establish the offering's investment merits or predict its share price. Use the NCAV formula to recreate the calculation with a documented share count.
If the business subsequently consumes 6 million without creating an offsetting asset, NCAV in this simplified scenario falls to 14 million, or approximately 0.47 per share. Separate that operating change from the financing itself. Otherwise, a ledger can incorrectly attribute all deterioration to issuance.
Examine the mechanism behind repeated issuance
A fixed-price financing, a warrant exercise, and a variable-price convertible create different claims. Record conversion formulas, floors, caps, resets, maturity dates, and restrictions rather than guessing the final share count. The SEC's convertible securities explanation describes how conversion terms can change the dilution mechanism.
Do not assume every authorized share will be issued, or that a registered offering has been completed. Distinguish the capacity to raise capital from capital actually raised. Treat unknown future issuance as an explicit uncertainty in the worksheet.
Write a monitoring rule you can verify
Instead of applying a universal percentage cutoff, record the assumptions that support the research case: the cash needed to reach the next operating milestone, financing already committed, potential additional shares, and the asset backing under each scenario. Revisit the case when a new filing contradicts those assumptions.
Use current-asset burn to identify a question about liquidity, then inspect the cash-flow statement to understand the cause. Current-asset movement is not itself a cash-runway calculation. Combine the financing ledger with the net-net risk worksheet and the broader Value Investing process.